These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4015025)

  • 1. Variation of estrogen and progesterone receptor status in breast cancer.
    Alanko A
    Ann Clin Res; 1985; 17(1):10-4. PubMed ID: 4015025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid receptors in breast cancer.
    Desombre ER
    Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interobserver reproducibility of immunocytochemical estrogen- and progesterone receptor status assessment in breast cancer.
    Biesterfeld S; Veuskens U; Schmitz FJ; Amo-Takyi B; Böcking A
    Anticancer Res; 1996; 16(5A):2497-500. PubMed ID: 8917341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of operative devascularization on estrogen and progesterone receptor levels in breast cancer specimens.
    Teicher I; Tinker MA; Auguste LJ; Laufer H; Stein TA; Wise L
    Surgery; 1985 Oct; 98(4):784-91. PubMed ID: 4049250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone and estrogen receptors as prognostic variables in breast cancer.
    Mason BH; Holdaway IM; Mullins PR; Yee LH; Kay RG
    Cancer Res; 1983 Jun; 43(6):2985-90. PubMed ID: 6850609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hormone receptors and breast cancer prognosis].
    Saez S; Pichon MF
    Pathol Biol (Paris); 1983 Dec; 31(10):801-8. PubMed ID: 6366701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of time and therapy on the hormone receptor status of breast carcinomas.
    Mobbs BG
    Can Med Assoc J; 1982 Aug; 127(3):217-21. PubMed ID: 6896673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oestrogen and progesterone receptor status of individual foci in multifocal invasive ductal breast cancer.
    Garimella V; Long ED; O'Kane SL; Drew PJ; Cawkwell L
    Acta Oncol; 2007; 46(2):204-7. PubMed ID: 17453370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seasonal variation in estrogen and progesterone receptor levels in breast cancer--a factor in data interpretation.
    Vyzula R; Zaloudík J; Dusek L; Vermousek I
    Neoplasma; 2001; 48(1):19-25. PubMed ID: 11327533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progesterone receptors in breast cancer].
    Vitola GIa; Zeĭkate GA; Grabovska IK
    Vopr Onkol; 1987; 33(9):35-8. PubMed ID: 3660754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with prognosis in human breast cancer. IV. Progesterone receptors and clinical factors.
    Macías A; Pascual MR; Pérez R; Lage A
    Neoplasma; 1983; 30(5):593-601. PubMed ID: 6656963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assay of estrogen and progesterone receptors in small samples of breast cancer: II. The conventional procedure compared to the mathematical one.
    Viticchi C; Basso A; Piantanelli L; Zaia A
    Boll Soc Ital Biol Sper; 1994; 70(8-9):229-34. PubMed ID: 7893481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Factors affecting estrogen and progesterone receptors in primary breast cancer].
    Kuno K; Fukami A; Hori M; Kasumi F; Yoshimoto K
    Gan No Rinsho; 1983 May; 29(6):621-7. PubMed ID: 6876431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple or sequential oestrogen receptor assays in breast cancer.
    Bennett RC; Mercer RJ; Lie TH
    Aust N Z J Surg; 1983 Jun; 53(3):231-6. PubMed ID: 6576774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone receptor status of breast cancer metastases.
    Branković-Magić M; Janković R; Nesković-Konstantinović Z; Nikolić-Vukosavljević D
    J Cancer Res Clin Oncol; 2002 Jan; 128(1):55-60. PubMed ID: 11862473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hormone receptors: clinical significance and problems in the treatment of breast cancer].
    Izuo M; Iino Y
    Gan No Rinsho; 1983 May; 29(6):637-43. PubMed ID: 6876433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
    J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision in estrogen and progesterone receptor assays. Results of the first CAP pilot survey.
    Oxley DK; Haven GT; Wittliff JL; Gilbo D
    Am J Clin Pathol; 1982 Oct; 78(4 Suppl):587-96. PubMed ID: 7137099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
    Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
    Anticancer Res; 1997; 17(2B):1417-23. PubMed ID: 9137508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen and progesterone receptors in breast cancer: relationships to tumour histopathology and survival of patients.
    Blanco G; Alavaikko M; Ojala A; Collan Y; Heikkinen M; Hietanen T; Aine R; Taskinen PJ
    Anticancer Res; 1984; 4(6):383-9. PubMed ID: 6097159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.